- Programs & Admissions
- Executive Education
- News & Ideas
Ellynne Dec is an actuary specialising in healthcare and pharmaceutical strategy. She is an expert in risk quantification and forecasting, working with sparse information and in a big-data environment. Ms Dec has dedicated her career to working with teams making difficult, high-stakes decisions involving uncertain, often unstructured, outcomes. As a graduate student, she studied Applied Mathematics at Colorado School of Mines, and Decision Analysis and Management Science with Professor Ron Howard at Stanford University.
She has worked as a drug development strategist at a global pharmaceutical company, and consults to public and private stakeholders in the international life sciences and health industry.
Her recent research has focused on:
- Evidence-based analysis of breast cancer screening and recall rates, and the costs of standard screening and follow-up to private insurers in the US
- Medicare patients with COPD and their annual patterns of consumption of hospital inpatient and outpatient resources
- The potential future impact of new therapies on global treatment trends and long-term prevalence of Hepatitis C
- Mechanisms for the UK DOH to incentivise and reward pharmaceutical innovation in the context of a reduced pricing scheme